These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 9267724

  • 1. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP, Kowdley KV, Emond MJ, Barr D, Marsh CL, Carithers RL, Perkins JD.
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [Abstract] [Full Text] [Related]

  • 2. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

  • 3. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

  • 4. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Glanemann M, Guckelberger O, Klupp J, Neumann U, Machens C, Lohmann R, Knoop M, Lobeck H, Schlag H, Keck H, Settmacher U, Bechstein WO, Neuhaus PJ.
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [Abstract] [Full Text] [Related]

  • 5. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 6. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D, Di Salvo T, Mathier M, Keck S, Semigran M, Dec GW.
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [Abstract] [Full Text] [Related]

  • 9. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 10. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [Abstract] [Full Text] [Related]

  • 11. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson M, Heroux A, Kao W, Mullen GM, Radvany R, Robinson J.
    J Heart Lung Transplant; 1993 Apr; 12(5):779-89. PubMed ID: 8241215
    [Abstract] [Full Text] [Related]

  • 12. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
    Slifkin M, Ruthazer R, Freeman R, Bloom J, Fitzmaurice S, Fairchild R, Angelis M, Cooper J, Barefoot L, Rohrer R, Snydman DR.
    Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
    [Abstract] [Full Text] [Related]

  • 13. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
    Fabregat J, Fradera R, Figueras J, Rafecas A, Torras J, Martinez LaCasa J, Baliellas C, Casais L, Jaurrieta E.
    Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845
    [No Abstract] [Full Text] [Related]

  • 14. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC, Schroeder TJ, Pedersen SH, Dittrich VS, Balistreri WF.
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [Abstract] [Full Text] [Related]

  • 15. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 16. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS, Ibrahim H, Tolman D, Kirchberg D, Salter D, Guerraty A, Mohanty PK.
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract] [Full Text] [Related]

  • 17. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]

  • 18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 May; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 19. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    Higgins R, Kirklin JK, Brown RN, Rayburn BK, Wagoner L, Oren R, Miller L, Flattery M, Bourge RC, Cardiac Transplant Research Database (CTRD).
    J Heart Lung Transplant; 2005 Apr; 24(4):392-400. PubMed ID: 15797738
    [Abstract] [Full Text] [Related]

  • 20. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I, Hsaiky L, Brown K, Abouljoud M.
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.